Marktanalyse - Diabetic Gastroparesis Global Clinical Trials Review, H1, 2012

Diabetic Gastroparesis Global Clinical Trials Review, H1, 2012


Summary


GlobalData's clinical trial report, 'Diabetic Gastroparesis Global Clinical Trials Review, H1, 2012' provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Gastroparesis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)


Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Diabetic Gastroparesis 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by BRIC Nations 13

Clinical Trials by G7 Nations 14

Clinical Trials in G7 Nations by Trial Status 15

Clinical Trials by E7 Nations 16

Clinical Trials in E7 Nations by Trial Status 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Unaccomplished Trials of Diabetic Gastroparesis 21

Subjects Recruited Over a Period of Time 22

Prominent Sponsors 23

Top Companies Participating in Diabetic Gastroparesis Therapeutics Clinical Trials 25

Prominent Drug Comparison 26

Clinical Trial Profiles 27

Clinical Trial Overview of Top Companies 27

Tranzyme Pharma, Inc. 27

Clinical Trial Overview of Tranzyme Pharma, Inc. 27

GlaxoSmithKline plc 28

Clinical Trial Overview of GlaxoSmithKline plc 28

Rhythm Pharmaceuticals 29

Clinical Trial Overview of Rhythm Pharmaceuticals 29

Evoke Pharma, Inc. 30

Clinical Trial Overview of Evoke Pharma, Inc. 30

Clinical Trial Overview of Top Universities / Institutes / Hospitals 31

Malmo University Hospital 31

Clinical Trial Overview of Malmo University Hospital 31

Yokohama City University 32

Clinical Trial Overview of Yokohama City University 32

Osaka City University 33

Clinical Trial Overview of Osaka City University 33

Mayo Clinic 34

Clinical Trial Overview of Mayo Clinic 34

Shaare Zedek Medical Center 35

Clinical Trial Overview of Shaare Zedek Medical Center 35

Duke University 36

Clinical Trial Overview of Duke University 36

Rabin Medical Center 37

Clinical Trial Overview of Rabin Medical Center 37

Five Key Clinical Profiles 38

Appendix 60

Abbreviations 60

Definitions 60

Research Methodology 61

Secondary Research 61

About GlobalData 62

Contact Us 62

Disclaimer 62

Source 63





List of Tables

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 6

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8

Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 9

Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10

Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2012* 11

Diabetic Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 12

Diabetic Gastroparesis Therapeutics Clinical Trials, BRIC Countries, 2012* 13

Diabetic Gastroparesis Therapeutics Clinical Trials, G7 Countries, 2012* 14

Diabetic Gastroparesis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15

Diabetic Gastroparesis Therapeutics Clinical Trials, E7 Countries, 2012* 16

Diabetic Gastroparesis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 18

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 19

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20

Diabetic Gastroparesis Therapeutics Market, Global, Suspended Clinical Trials, 2012* 21

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tranzyme Pharma, Inc., 2012* 27

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 28

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rhythm Pharmaceuticals, 2012* 29

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Evoke Pharma, Inc., 2012* 30

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Malmo University Hospital, 2012* 31

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2012* 32

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2012* 33

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 34

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2012* 35

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 36

Diabetic Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2012* 37





List of Figures

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 6

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8

Diabetic Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 9

Diabetic Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 10

Diabetic Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 11

Diabetic Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 12

Diabetic Gastroparesis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 13

Diabetic Gastroparesis Therapeutics Clinical Trials, G7 Countries (%), 2012* 14

Diabetic Gastroparesis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15

Diabetic Gastroparesis Therapeutics Clinical Trials, E7 Countries (%), 2012* 16

Diabetic Gastroparesis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 17

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 18

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 19

Diabetic Gastroparesis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 20

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25

Diabetic Gastroparesis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 26

GlobalData Methodology 61

• Growth Hormone Deficiency – Pipeline Review, H1 2013
• Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H1 2013
• Growth Disorders – Pipeline Review, H1 2013
• Kidney Fibrosis – Pipeline Review, H1 2013
• Urinary Incontinence – Pipeline Review, H1 2013
• Global Endocrinology Drugs Market 2012-2016
• Inguinal Hernia Global Clinical Trials Review, H1, 2013
• End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Pipeline Review, H2 2012
• Microalbuminuria – Pipeline Review, H2 2012
• Nocturia – Pipeline Review, H2 2012
• Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2012
• Hypoparathyroidism – Pipeline Review, H2 2012
• Proteinuria – Pipeline Review, H2 2012
• Thyroid Gland Disorders – Pipeline Review, H2 2012
• Acute Renal Failure (ARF) (Acute Kidney Injury) – Pipeline Review, H2 2012
• Hypothyroidism Global Clinical Trials Review, H2, 2012
• Interstitial Cystitis (Painful Bladder Syndrome) – Pipeline Review, H2 2012
• Other Genito Urinary Disorders – Pipeline Review, H2 2012
• Urinary Retention Global Clinical Trials Review, H2, 2012
• Focal Segmental Glomerulosclerosis (FSGS) – Pipeline Review, H2 2012